Regenerative Medicine for the Inner Ear: Summary
Reference7 articles.
1. Lidian A, Stenkvist-Asplund M, Linder B, Anniko M, Nordang L. Early hearing protection by brain-derived neurotrophic factor. Acta Otolaryngol. 2013;133:12–21. doi:
10.3109/00016489.2012.712217
.
2. Ruan RS, Leong SK, Mark I, Yeoh KH. Effects of BDNF and NT-3 on hair cell survival in guinea pig cochlea damaged by kanamycin treatment. Neuroreport. 1999;10:2067–7.
3. Nakagawa T, Sakamoto T, Hiraumi H, Kikkawa YS, Yamamoto N, Hamaguchi K, et al. Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial. BMC Med. 2010;8:76.
4. Lee KY, Nakagawa T, Okano T, Hori R, Ono K, Tabata Y, et al. Novel therapy for hearing loss: delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel. Otol Neurotol. 2007;28:976–81.
5. Izumikawa M, Minoda R, Kawamoto K, Abrashkin KA, Swiderski DL, Dolan DF, et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med. 2005;11(3):271–6.